Home
Conditions
Neoplasms, Ductal, Lobular, and Medullary

Clinical trial condition

Neoplasms, Ductal, Lobular, and Medullary

Explore clinical trials studying Neoplasms, Ductal, Lobular, and Medullary. Study availability and eligibility vary by location and protocol.

477 public trials 97 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Ductal, Lobular, and Medullary trial results

Completed

Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer

NCT02199418

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +15 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

Shanghai Jiaotong University School of Medicine, Renji Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

NCT00005886

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations: University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States

Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Comprehensive Cancer Centers of the Desert Palm Springs, California, United States

Loyola University Medical Center Maywood, Illinois, United States

View Trial Details

Completed

A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

NCT00637481

Conditions: Adenocarcinoma, Atypical Ductal Breast Hyperplasia, Breast Cancer, +15 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial

NCT01372644

Conditions: Adenocarcinoma, Atypical Ductal Breast Hyperplasia, Atypical Lobular Hyperplasia (ALH) of Breast, +14 more
Locations: NYU School of Medicine New York, United States

View Trial Details

Completed

Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid Carcinoma

NCT01661179

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +14 more
Locations: Research Site Fukuoka, Japan

Research Site Kobe, Japan

Research Site Kōtoku, Japan

Research Site Shinjuku-ku, Japan

View Trial Details

Completed

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

NCT00154388

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +121 more
Locations: Not specified

View Trial Details

Completed

Molecular Breast Imaging in Women With Atypia and LCIS

NCT00620087

Conditions: Adenocarcinoma, Atypical Ductal Hyperplasia, Atypical Lobular Hyperplasia, +14 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Multipeptide Vaccine for Advanced Breast Cancer

NCT00573495

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +12 more
Locations: University of Pennsylvania Medical Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Vandetanib Risk Minimisation Effectiveness

NCT01757470

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
Locations: Research Site Montreal, Quebec, Canada

View Trial Details

Completed

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

NCT00438659

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +18 more
Locations: Rush-Copley Cancer Care Center Aurora, Illinois, United States

St. Joseph Medical Center Bloomington, Illinois, United States

Graham Hospital Canton, Illinois, United States

Memorial Hospital Carthage, Illinois, United States

View all 189 locations

View Trial Details

Neoplasms, Ductal, Lobular, and Medullary

Neoplasms, Ductal, Lobular, and Medullary trial results

Related conditions